Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imaging
IA Minciună, O Hilda Orășan, I Minciună… - European Journal of …, 2021 - Wiley Online Library
Background Diastolic dysfunction is traditionally believed to be the first subclinical
manifestation of diabetic cardiomyopathy (DCM), leading to systolic dysfunction and then …
manifestation of diabetic cardiomyopathy (DCM), leading to systolic dysfunction and then …
Sex and ethnic differences in the cardiovascular complications of type 2 diabetes
Diabetes mellitus represents a global health concern affecting 463 million adults and is
projected to rapidly rise to 700 million people by 2045. Amongst those with type 2 diabetes …
projected to rapidly rise to 700 million people by 2045. Amongst those with type 2 diabetes …
[HTML][HTML] Renal sinus fat volume in type 2 diabetes mellitus is associated with glycated hemoglobin and metabolic risk factors
Aims We aimed to compare renal sinus fat volume assessed by MRI between patients with
type 2 diabetes and healthy volunteers, and investigate the association between renal sinus …
type 2 diabetes and healthy volunteers, and investigate the association between renal sinus …
[HTML][HTML] The effect of glycemic control on renal triglyceride content assessed by proton spectroscopy in patients with type 2 diabetes mellitus: A single-center parallel …
IA Dekkers, MB Bizino, EHM Paiman, JW Smit… - Journal of Renal …, 2021 - Elsevier
Objective Ectopic lipid accumulation in the kidney (fatty kidney) is a potential driver of
diabetic kidney disease, and tight glycemic control can reduce risk of diabetic nephropathy …
diabetic kidney disease, and tight glycemic control can reduce risk of diabetic nephropathy …
[HTML][HTML] Novel insights into the pathogenesis of diabetic cardiomyopathy and pharmacological strategies
F Muñoz-Córdova, C Hernández-Fuentes… - Frontiers in …, 2021 - frontiersin.org
Diabetic cardiomyopathy (DCM) is a severe complication of diabetes developed mainly in
poorly controlled patients. In DCM, several clinical manifestations as well as cellular and …
poorly controlled patients. In DCM, several clinical manifestations as well as cellular and …
Evaluation of the effects of glycated hemoglobin on cardiac function in patients with short-duration type 2 diabetes mellitus: A cardiovascular magnetic resonance …
F Zhou, M Deng, LL Deng, Y Li, D Mo, L Xie… - Diabetes Research and …, 2021 - Elsevier
Aims To investigate the association between glycated hemoglobin (HbA1c) and myocardial
dysfunction and to determine whether its association is independent of myocardial …
dysfunction and to determine whether its association is independent of myocardial …
[HTML][HTML] Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?
Q Zhang, Y Kang, S Tang, CM Yu - Current Cardiology Reports, 2021 - Springer
Abstract Purpose of Review Diabetes mellitus (DM) is a major comorbidity of heart failure
(HF). Comparing the similarities and differences in disease characteristics and treatment …
(HF). Comparing the similarities and differences in disease characteristics and treatment …
[HTML][HTML] Energiestoffwechsel des humanen Myokards bei Herzinsuffizienz und Diabetes Mellitus Typ 2
E Zweck - docserv.uni-duesseldorf.de
Beschreibungen: Typ 2 Diabetes Mellitus (T2DM) kann unabhängig von anderen
Risikofaktoren zu einer Herzinsuffizienz führen. Jüngere Studien geben Hinweise darauf …
Risikofaktoren zu einer Herzinsuffizienz führen. Jüngere Studien geben Hinweise darauf …